Literature DB >> 19444095

Conduct of clinical trials in developing countries: a perspective.

Niveditha Devasenapathy1, Kavita Singh, Dorairaj Prabhakaran.   

Abstract

PURPOSE OF REVIEW: To provide a broad perspective of contextual factors involved in the conduct of clinical trials in developing countries. RECENT
FINDINGS: The quantity of research in developing countries continues to be inadequate, with clinical trials comprising a small fraction of the total research output. Most trials done in developing countries tend to be designed in developed countries and led by investigators in those nations. The main challenges in the conduct of trials in developing countries stem from the vulnerability of the populations due to illiteracy, poverty, limited research infrastructure, lack of sufficient numbers of experienced investigators and trained support personnel, and fragmented healthcare system.
SUMMARY: There is a need to formulate and conduct trials to test treatments that are context-specific and socially relevant. With careful planning in advance and shared partnership among sponsors, host-country research practitioners, government agencies and the community, many of the challenges facing clinical trial research can be overcome over the medium to long term. This would enable conformity to contemporary guidelines in both letter and spirit and hopefully develop research questions addressing the needs of developing countries.

Mesh:

Year:  2009        PMID: 19444095     DOI: 10.1097/HCO.0b013e32832af21b

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  16 in total

Review 1.  Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.

Authors:  Amy Grenham; Tonya Villafana
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

2.  Geographic location of antineoplastic agent clinical trials conducted in developed and developing countries.

Authors:  Feng Lu; Katie J Suda; Katherine E Marks
Journal:  Int J Clin Pharm       Date:  2012-10-10

Review 3.  Cancer Research in the Arab World: A review of publications from seven countries between 2000-2013.

Authors:  Randah R Hamadeh; Saif M Borgan; Abla M Sibai
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

4.  The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial.

Authors:  Lawrence Mbuagbaw; Lehana Thabane; Pierre Ongolo-Zogo; Trudie Lang
Journal:  Trials       Date:  2011-06-09       Impact factor: 2.279

5.  Trial watch: global migration of clinical trials.

Authors:  Paul K Drain; Marion Robine; King K Holmes; Ingrid V Bassett
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

6.  Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.

Authors:  Augustine N Odili; Birinus Ezeala-Adikaibe; Mouhamadou B Ndiaye; Benedict C Anisiuba; Marius M Kamdem; Chinwuba K Ijoma; Joseph Kaptue; Hilaire J Boombhi; Philip M Kolo; Elvis N Shu; Lutgarde Thijs; Jan A Staessen; Babatunde A Omotoso; Samuel Kingue; Serigne A Ba; Daniel Lemogoum; Jean-René M'Buyamba-Kabangu; Ifeoma I Ulasi
Journal:  Trials       Date:  2012-05-17       Impact factor: 2.279

Review 7.  Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature.

Authors:  Samuel R P Franzen; Clare Chandler; Trudie Lang
Journal:  BMJ Open       Date:  2017-01-27       Impact factor: 2.692

8.  "You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.

Authors:  Nerina Vischer; Constanze Pfeiffer; Manuela Limacher; Christian Burri
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

9.  Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia.

Authors:  Samuel R P Franzen; Clare Chandler; Fikre Enquselassie; Sisira Siribaddana; Julius Atashili; Brian Angus; Trudie Lang
Journal:  BMJ Open       Date:  2013-11-27       Impact factor: 2.692

10.  Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study.

Authors:  Nerina Vischer; Constanze Pfeiffer; Jennifer Kealy; Christian Burri
Journal:  Glob Health Res Policy       Date:  2017-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.